Aurora Cannabis Financials
| ACB Stock | USD 4.54 0.13 2.95% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Debt Equity Ratio | 0.18 | 0.1872 |
|
| |||||
| Current Ratio | 3.25 | 3.4232 |
|
|
Investors should never underestimate Aurora Cannabis' ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Aurora Cannabis' cash flow, debt, and profitability to make informed and accurate decisions about investing in Aurora Cannabis.
Net Income |
|
Aurora | Select Account or Indicator |
Understanding current and past Aurora Cannabis Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Aurora Cannabis' financial statements are interrelated, with each one affecting the others. For example, an increase in Aurora Cannabis' assets may result in an increase in income on the income statement.
Please note, the presentation of Aurora Cannabis' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aurora Cannabis' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Aurora Cannabis' management manipulating its earnings.
Aurora Cannabis Stock Summary
Aurora Cannabis competes with Canopy Growth, SNDL, Cronos, Curaleaf Holdings, and OrganiGram Holdings. Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. The companys adult-use brand portfolio includes Aurora Drift, San Rafael 71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7 and medical cannabis brands include MedReleaf, CanniMed, Aurora, and WMMC. Aurora Cannabis is traded on NASDAQ Exchange in the United States.| Foreign Associate | Canada |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | CA05156X8843 |
| CUSIP | 05156X884 05156X108 05156X850 |
| Location | Alberta; Canada |
| Business Address | 90B Street SW, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.auroramj.com |
| Phone | 855 279 4652 |
| Currency | USD - US Dollar |
Aurora Cannabis Key Financial Ratios
| Return On Equity | -0.0579 | ||||
| Profit Margin | (0.15) % | ||||
| Operating Margin | (0.02) % | ||||
| Price To Sales | 0.84 X | ||||
| Revenue | 270.28 M |
Aurora Cannabis Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 2.8B | 2.6B | 1.1B | 926.3M | 838.7M | 978.8M | |
| Other Current Liab | 21.1M | 40.0M | 79.5M | 49.0M | 21.0M | 39.4M | |
| Net Debt | 369.1M | (21.9M) | (168.3M) | (73.3M) | (8.6M) | (8.2M) | |
| Retained Earnings | (3.6B) | (4.3B) | (6.0B) | (6.3B) | (6.4B) | (6.0B) | |
| Accounts Payable | 95.6M | 13.3M | 13.9M | 21.9M | 20.3M | 16.1M | |
| Cash | 162.2M | 421.5M | 437.8M | 300.8M | 113.4M | 113.9M | |
| Net Receivables | 54.1M | 56.5M | 47.1M | 41.3M | 45.4M | 23.2M | |
| Total Liab | 657.2M | 567.0M | 422.0M | 409.2M | 236.8M | 237.1M | |
| Total Current Assets | 420.7M | 665.9M | 745.1M | 479.9M | 426.6M | 234.2M | |
| Other Current Assets | 22.1M | 11.2M | 6.5M | 8.9M | 9.4M | 8.2M | |
| Common Stock | 5.8B | 6.4B | 6.8B | 6.8B | 7.0B | 3.6B | |
| Short Term Debt | 152.6M | 40.9M | 33.0M | 147.6M | 57.2M | 69.6M | |
| Intangible Assets | 412.3M | 367.4M | 70.7M | 61.4M | 40.9M | 38.8M | |
| Other Liab | 280.3M | 5.8M | 92.0M | 40.3M | 46.3M | 67.7M | |
| Net Tangible Assets | 506.6M | 792.0M | 774.7M | 588.0M | 676.2M | 467.5M | |
| Other Assets | 93.3M | 57.8M | 77.3M | 33.9M | 38.9M | 53.7M | |
| Long Term Debt | 294.9M | 293.2M | 199.7M | 4.9M | 5.6M | 5.4M | |
| Good Will | 3.2B | 928.4M | 887.7M | 18.7M | 43.2M | 41.0M | |
| Inventory | 157.3M | 137.7M | 139.9M | 128.8M | 186.4M | 107.2M | |
| Short Long Term Debt | 152.6M | 34.7M | 26.9M | 52.4M | 47.1M | 44.8M |
Aurora Cannabis Key Income Statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 77.5M | 66.4M | 71.8M | 39.5M | 14.2M | 19.2M | |
| Operating Income | (491.0M) | (282.8M) | (231.4M) | (254.3M) | (46.5M) | (48.8M) | |
| Ebit | (508.1M) | (235.3M) | (236.7M) | (254.3M) | (12.6M) | (13.2M) | |
| Ebitda | (393.2M) | (137.2M) | (143.1M) | (210.7M) | 20.5M | 21.5M | |
| Net Income | (3.3B) | (693.6M) | (1.7B) | (265.3M) | (69.3M) | (72.8M) | |
| Income Tax Expense | (83.4M) | (6.3M) | (2.1M) | (20.3M) | (554K) | (581.7K) | |
| Total Revenue | 278.9M | 245.3M | 221.3M | 233.3M | 270.3M | 157.2M | |
| Gross Profit | (33.5M) | (21.6M) | 21.2M | (64.4M) | 131.5M | 138.0M | |
| Income Before Tax | (3.4B) | (699.8M) | (1.7B) | (295.4M) | (59.6M) | (62.6M) | |
| Research Development | 26.1M | 11.4M | 10.4M | 6.6M | 3.6M | 3.4M | |
| Cost Of Revenue | 312.4M | 266.8M | 200.1M | 297.6M | 138.8M | 145.1M | |
| Minority Interest | (24.4M) | 1.5M | 355K | 2.1M | 1.9M | 1.9M | |
| Tax Provision | (83.4M) | (6.3M) | (2.1M) | (13.6M) | (554K) | (581.7K) | |
| Net Interest Income | (72.5M) | (60.7M) | (67.3M) | (51.5M) | (1.4M) | (1.4M) | |
| Interest Income | 56.6M | 5.7M | 4.5M | 9.9M | 12.8M | 12.2M |
Aurora Cannabis Key Cash Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (10.5M) | 259.3M | 16.4M | (140.0M) | (121.5M) | (115.4M) | |
| Free Cash Flow | (693.0M) | (263.7M) | (142.1M) | (128.0M) | (85.5M) | (89.7M) | |
| Capital Expenditures | 355.0M | 53.1M | 32.2M | 12.1M | 17.0M | 16.1M | |
| Net Income | (3.3B) | (693.5M) | (1.7B) | (265.3M) | (59.0M) | (62.0M) | |
| End Period Cash Flow | 162.2M | 421.5M | 437.8M | 300.8M | 113.4M | 113.9M | |
| Depreciation | 114.9M | 98.1M | 93.7M | 43.6M | 33.1M | 31.4M | |
| Other Non Cash Items | 2.9B | 370.6M | 1.5B | 190.1M | (70.8M) | (67.3M) | |
| Change To Inventory | (29.4M) | 8.5M | 21.1M | 49.0M | 3.6M | 3.8M | |
| Investments | (249.5M) | 18.1M | (36.6M) | (54.7M) | (5.5M) | (5.8M) | |
| Net Borrowings | 583.7M | (38.8M) | (122.9M) | (170.8M) | (153.7M) | (146.1M) | |
| Change To Netincome | 50.3M | 2.8B | 384.6M | 1.5B | 1.7B | 1.8B |
Aurora Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Aurora Cannabis's current stock value. Our valuation model uses many indicators to compare Aurora Cannabis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aurora Cannabis competition to find correlations between indicators driving Aurora Cannabis's intrinsic value. More Info.Aurora Cannabis is rated third in return on equity category among its peers. It is number one stock in return on asset category among its peers . At present, Aurora Cannabis' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aurora Cannabis' earnings, one of the primary drivers of an investment's value.Aurora Cannabis Systematic Risk
Aurora Cannabis' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Aurora Cannabis volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Aurora Cannabis correlated with the market. If Beta is less than 0 Aurora Cannabis generally moves in the opposite direction as compared to the market. If Aurora Cannabis Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Aurora Cannabis is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Aurora Cannabis is generally in the same direction as the market. If Beta > 1 Aurora Cannabis moves generally in the same direction as, but more than the movement of the benchmark.
Aurora Cannabis Thematic Clasifications
Aurora Cannabis is part of Cannabis investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Companies involved in production or distribution of medical cannabis. Equities that are involved in production and delivery of legal cannabis. This theme is designed for investors that are willing to accept higher levels of market risk inherited by cannabis production and distribution globally
This theme covers Companies involved in production or distribution of medical cannabis. Equities that are involved in production and delivery of legal cannabis. This theme is designed for investors that are willing to accept higher levels of market risk inherited by cannabis production and distribution globally. Get More Thematic Ideas
| Cannabis | View |
Today, most investors in Aurora Cannabis Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Aurora Cannabis' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Aurora Cannabis growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Aurora Cannabis November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Aurora Cannabis help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Aurora Cannabis. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aurora Cannabis based on widely used predictive technical indicators. In general, we focus on analyzing Aurora Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aurora Cannabis's daily price indicators and compare them against related drivers.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 26.91 | |||
| Value At Risk | (4.58) | |||
| Potential Upside | 5.3 |
Complementary Tools for Aurora Stock analysis
When running Aurora Cannabis' price analysis, check to measure Aurora Cannabis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aurora Cannabis is operating at the current time. Most of Aurora Cannabis' value examination focuses on studying past and present price action to predict the probability of Aurora Cannabis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aurora Cannabis' price. Additionally, you may evaluate how the addition of Aurora Cannabis to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |